Mei-Yin Zhang
Overview
Explore the profile of Mei-Yin Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
1076
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cao D, Wang Y, Sun C, Li H, Ren G, Zhou Y, et al.
J Immunother Cancer
. 2025 Jan;
13(1.
PMID: 39800372
Background: The biological significance of MAF1, a tumor suppressor, in carcinogenesis and immune response of hepatocellular carcinoma (HCC) remains unreported. Understanding the underlying mechanisms by which MAF1 enhances anti-tumor immunity...
2.
Sun C, Cao D, Wang Y, Weng N, Ren Q, Wang S, et al.
Cell Death Dis
. 2024 Sep;
15(9):704.
PMID: 39349433
Repositioning approved antitumor drugs for different cancers is a cost-effective approach. Gilteritinib was FDA-approved for the treatment of FLT3-mutated acute myeloid leukemia in 2018. However, the therapeutic effects and mechanism...
3.
Wang Y, Cao D, Liu J, Ren Q, Weng N, Zhou Y, et al.
Cell Signal
. 2024 Jul;
122:111298.
PMID: 39004325
Circular RNAs (circRNAs) are covalently closed, single-stranded RNAs that play critical roles in various biological processes and diseases, including cancers. However, the functions and mechanisms of circRNAs in hepatocellular carcinoma...
4.
Yin Y, Shi L, Wu C, Zhang M, Li J, Zhou Y, et al.
Med Oncol
. 2024 Feb;
41(3):79.
PMID: 38393440
Tripartite motif-containing 29 (TRIM29), also known as the ataxia telangiectasia group D-complementing (ATDC) gene, has been reported to play an oncogenic or tumor suppressive role in developing different tumors. So...
5.
Ren Q, Huang D, Zhang X, Wang Y, Zhou Y, Zhang M, et al.
Commun Biol
. 2024 Jan;
7(1):22.
PMID: 38182647
The androgen receptor (AR) plays an important role in male-dominant hepatocellular carcinoma, and specific acquired somatic mutations of AR have been observed in HCC patients. Our previous research have established...
6.
Wang J, Wang F, Wang N, Zhang M, Wang H, Huang G
J Clin Transl Hepatol
. 2023 Aug;
11(5):1192-1200.
PMID: 37577238
Hepatocellular carcinoma (HCC) is a common malignant tumor with high incidence and cancer mortality worldwide. Post-translational modifications (PTMs) of proteins have a great impact on protein function. Almost all proteins...
7.
Ren Q, Zhang H, Sun C, Zhou Y, Yang X, Long J, et al.
Hepatology
. 2021 Aug;
75(5):1123-1138.
PMID: 34435708
Background And Aims: Androgen receptor (AR) has been reported to play an important role in the development and progression of man's prostate cancer. Hepatocellular carcinoma (HCC) is also male-dominant, but...
8.
Sun C, Li Y, Cao D, Zhou Y, Zhang M, Wang H
Int J Biol Sci
. 2021 Aug;
17(12):3211-3223.
PMID: 34421360
Mammalian target of rapamycin (mTOR) is one of the most commonly activated pathways in human cancers, including lung cancer. Targeting mTOR with molecule inhibitors is considered as a useful therapeutic...
9.
Wang R, Long X, Zhou N, Chen D, Zhang M, Wen Z, et al.
J Exp Clin Cancer Res
. 2021 Jan;
40(1):9.
PMID: 33407724
Background: Long non-coding RNAs (lncRNAs) play vital roles in the development and progression of non-small-cell lung cancer (NSCLC); however, the role of most lncRNAs in NSCLC remains unknown. This study...
10.
Wang R, Long X, Ge C, Zhang M, Huang L, Zhou N, et al.
J Transl Med
. 2020 Aug;
18(1):320.
PMID: 32819367
Background: Previous findings have indicated that the tumor, nodes, and metastases (TNM) staging system is not sufficient to accurately predict survival outcomes in patients with non-small lung carcinoma (NSCLC). Thus,...